Peritoneal dialysis outcomes in patients with nephrotic syndrome: a propensity score-matched cohort study.

It is unclear whether patients with end-stage renal disease (ESRD) and nephrotic syndrome (NS) can be treated with peritoneal dialysis (PD). To investigate the outcomes of PD treatment in ESRD patients with or without NS. In this retrospective cohort study, all incident patients with ESRD and NS who started PD from 1 February 2006 to 31 December 2017, were matched with patients without NS using propensity scores based on age, sex, diabetes mellitus status, and serum albumin. Fifty-three patients in the NS PD group and 53 matched controls were included. The median survival of the NS PD group was comparable to that of the non-NS PD group. An interaction effect was observed between survival time and baseline NS status. Thus, patients' outcomes within and after 1.5 years were analyzed separately. Both mortality (log-rank test, Our study indicates that PD may be considered as a long-term renal replacement therapy for patients with ESRD and baseline NS.